Showing results (101-110 of 697) with videos related to
Sort By:
Pageof 70
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 14, 2018
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.Blood Reviews|March 21, 2007
Monoclonal gammopathy of undetermined significance and smoldering multiple myelomaS Vincent Rajkumar, Martha Q Lacy, Robert A KyleBlood|December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timingShaji K Kumar, Francis K Buadi, S Vincent RajkumarSeminars in Oncology|January 10, 2003
Myeloma and the newly diagnosed patient: a focus on treatment and managementS Vincent Rajkumar, Robert A Kyle, Morie A GertzMayo Clinic Proceedings|May 6, 2017
Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and ManagementHafsa M Chaudhry, Michelle L Mauermann, S Vincent RajkumarBlood|February 23, 2012
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristicsAlexandra J Greenberg, S Vincent Rajkumar, Celine M VachonCurrent Hematologic Malignancy Reports|March 31, 2020
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future ProspectsShivani Seth, Saurabh Zanwar, Linh Vu, et al.Best Practice & Research. Clinical Haematology|November 10, 2016
Prognostic factors and indications for treatment of Waldenström's MacroglobulinemiaRobert A Kyle, Stephen M Ansell, Prashant KapoorCurrent Hematologic Malignancy Reports|March 27, 2024
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström MacroglobulinemiaReema K Tawfiq, Jithma P Abeykoon, Prashant KapoorAmerican Journal of Hematology|August 29, 2006
Splenectomy in plasma cell dyscrasias: a review of the clinical practicePrashant Kapoor, Ekta Singh, Priya Radhakrishnan, et al.Pageof 70